Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Second Primary × Bleomycin × 1 year × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Hodgkin Disease 9 Lymphoma 4 Neoplasms, Germ Cell and Embryonal 3 Vulvar Neoplasms 1 Teratoma 1 Seminoma 1 Neoplasms, Second Primary 1 Neoplasms 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Hemangioma, Capillary 1 Endodermal Sinus Tumor 1 Desmoid Tumors 1 Carcinoma, Embryonal 1 Ann Arbor Stage IIB Hodgkin Lymphoma 1

Interventions

avelumab 1 Varenicline 1 Tyrosine Kinase Inhibitors 1 Trastuzumab 1 Tobacco Use Cessation Devices 1 Registries 1 Probiotics 1 Patient Reported Outcome Measures 1 Nicotine Chewing Gum 1 Leucovorin 1 Lenalidomide 1 Irinotecan 1 Interviews as Topic 1 Fluorouracil 1 Cisplatin 1 Cetuximab 1 Bupropion 1 Bleomycin 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03199300 2025-12-11

InvestiCAT

University Medical Center Groningen

Active not recruiting

Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡